Nanoparticle delivery of innate immune agonists combines with senescence-inducing agents to mediate T cell control of pancreatic cancer
L. Chibaya, C. F. Lusi, K. D. DeMarco, G. I. Kane, M. L. Brassil, C. N. Parikh, K. C. Murphy, J. Li, T. E. Naylor, J. Cerrutti, J. Peura, J. R. Pitarresi, L. J. Zhu, K. A. Fitzgerald, P. U. Atukorale, M. A. Ruscetti
This paper combines nanoparticle-delivered immune agonists with senescence-inducing agents to enhance T cell responses and control pancreatic cancer in preclinical models.
bioRxiv · Sep 18, 2023 · PreprintCancer Biology